Bortezomib: a proteasome inhibitor with an evolving role in select subtypes of B-cell non-Hodgkin's lymphoma.
about
Protein kinase CK2 inhibition down modulates the NF-κB and STAT3 survival pathways, enhances the cellular proteotoxic stress and synergistically boosts the cytotoxic effect of bortezomib on multiple myeloma and mantle cell lymphoma cells.The truncate mutation of Notch2 enhances cell proliferation through activating the NF-κB signal pathway in the diffuse large B-cell lymphomas.Combined bortezomib-based chemotherapy and p53 gene therapy using hollow mesoporous silica nanospheres for p53 mutant non-small cell lung cancer treatment.Bendamustine for indolent non-Hodgkin lymphoma in the front-line or relapsed setting: a review of pharmacokinetics and clinical trial outcomes.
P2860
Bortezomib: a proteasome inhibitor with an evolving role in select subtypes of B-cell non-Hodgkin's lymphoma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Bortezomib: a proteasome inhib ...... B-cell non-Hodgkin's lymphoma.
@en
Bortezomib: a proteasome inhib ...... B-cell non-Hodgkin's lymphoma.
@nl
type
label
Bortezomib: a proteasome inhib ...... B-cell non-Hodgkin's lymphoma.
@en
Bortezomib: a proteasome inhib ...... B-cell non-Hodgkin's lymphoma.
@nl
prefLabel
Bortezomib: a proteasome inhib ...... B-cell non-Hodgkin's lymphoma.
@en
Bortezomib: a proteasome inhib ...... B-cell non-Hodgkin's lymphoma.
@nl
P2860
P356
P1433
P1476
Bortezomib: a proteasome inhib ...... B-cell non-Hodgkin's lymphoma.
@en
P2093
Bruce D Cheson
Jamie L Koprivnikar
P2860
P304
P356
10.2217/FON.12.23
P407
P577
2012-04-01T00:00:00Z